Skip to main content

Table 1 Incident users of any blood glucose-lowering drug, oral antidiabetic drugs (OAD) and insulins only*

From: No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study

  

Any blood glucose-lowering drug (A10)

OAD (A10B)

Insulins only (A10A only)

Year

Person years

No of patients

Incidence rate per 100,000 person years

95% confidence interval

No of patients

Incidence rate per 100,000 person years

95% confidence interval

No of patients

Incidence rate per 100,000 person years

95% confidence interval

Women

          

2006

2,347,036

7,531

320

(314, 328)

6,752

288

(281, 295)

670

29

(26, 31)

2007

2,366,461

7,769

328

(321, 336)

6,927

293

(286, 300)

679

29

(27, 31)

2008

2,390,716

7,677

321

(314, 328)

6,717

281

(274, 288)

783

33

(31, 35)

2009

2,418,595

7,832

323

(317, 331)

6,912

286

(279, 293)

745

31

(29, 33)

2010

2,445,249

7,778

318

(311, 325)

6,817

279

(272, 286)

784

32

(30, 34)

2011

2,473,228

7,269

293

(287, 301)

6,369

258

(251, 264)

  

Men

          

2006

2,314,006

7,829

338

(331, 346)

6,830

295

(288, 302)

756

33

(30, 35)

2007

2,342,823

8,374

357

(350, 365)

7,326

313

(306, 320)

793

34

(32, 36)

2008

2,377,361

8,655

364

(356, 372)

7,498

315

(308, 323)

845

36

(33, 38)

2009

2,411,205

8,620

357

(350, 365)

7,453

309

(302, 316)

839

35

(33, 37)

2010

2,443,697

8,605

352

(345, 360)

7,475

306

(299, 313)

813

33

(31, 36)

2011

2,479,989

8,246

332

(325, 340)

7,131

288

(281, 294)

  

Total

          

2006

4,661,041

15,360

329

(324, 334)

13,582

291

(287, 297)

1,426

31

(29, 32)

2007

4,709,284

16,143

342

(338, 348)

14,253

303

(298, 308)

1,472

31

(30, 33)

2008

4,768,077

16,332

342

(337, 348)

14,215

298

(293, 303)

1,628

34

(33, 36)

2009

4,829,800

16,452

340

(335, 346)

14,365

297

(293, 302)

1,584

33

(31, 34)

2010

4,888,946

16,383

335

(330, 340)

14,292

292

(288, 297)

1,597

33

(31, 34)

2011

4,953,217

15,515

313

(308, 318)

13,500

273

(268, 277)

  
  1. *Incident use is defined as no use of blood glucose-lowering drugs in the previous 24 months. In addition, for insulins only no OAD was dispensed in the subsequent 12 months.
  2. For insulins only users there are no data for 2011 due to the definition applied, requiring a 12 month follow up period after first insulin prescription filled.